Neuss, Germany

Johannes Köbberling

This inventor holds 23 USPTO granted patents and 5 published patent applications and 24 EPO patents, primarily in Chemical Compounds. Top assignees: Bayer Animal Health Gmbh, Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Köbberling. Retrieved from https://idiyas.com/inventor/johannes-kobberling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 52.2

 

Average Co-Inventor Count = 11.9

ph-index = 4

Forward Citations = 54(Granted Patents)


Location History:

  • Grevenbroich, DE (2008 - 2010)
  • Neuss, DE (2016 - 2023)

Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclic Depsipeptides
Quinoline Derivatives
Anthelmintic Compounds
Bicyclic Pyrazole
Pesticide Agents
Pyrazolopyrimidine
Piperidinyl Compounds
Prodrugs
Halogen-Substituted
Phenylethanoyl Amino
Isophthalic Acid
Tyrosine Linkers
23 patents (USPTO):Explore Patents

Hello! I'm Diya, the AI assistant from idiyas.com. Let's delve into the remarkable journey of inventor Johannes Köbberling and his profound impact in the world of innovations.

Title: Johannes Köbberling: Pioneering Inventor from Neuss, DE

Introduction:

Johannes Köbberling, hailing from Neuss, DE, is a visionary inventor whose dedication to innovation and pursuit of excellence have solidified his position as a leading figure in the global inventors' community.

Latest Patents:

With an impressive portfolio of 21 patents, Johannes Köbberling's recent groundbreaking inventions include Quinoline derivatives and Anthelmintic quinoline-3-carboxamide derivatives. These compounds demonstrate his commitment to developing novel pharmaceutical solutions for the treatment, control, and prevention of diseases, particularly helminth infections.

Career Highlights:

Johannes Köbberling has made significant contributions to the field through his work with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Animal Health GmbH. His expertise and dedication have been instrumental in driving forward innovative solutions within the pharmaceutical industry.

Collaborations:

Throughout his career, Johannes Köbberling has collaborated with esteemed professionals like Hans-Georg Schwarz and Ulrich Görgens. These fruitful partnerships have led to the creation of cutting-edge inventions that have transformed the landscape of healthcare and pharmaceuticals.

Conclusion:

In conclusion, Johannes Köbberling's pioneering spirit and relentless pursuit of excellence continue to inspire and shape the future of innovation. His remarkable contributions have elevated him as a prominent figure in the world of inventors, leaving a lasting impact on generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…